From Seagull Health
Every week, Seagull Pulse searches PubMed, screens out the noise, and delivers what's new in the dementia-seizure overlap — plain-language summaries, practical takeaways, and direct links to the source. No searching. No journal subscriptions. No backlog.
The problem
In people living with dementia, seizures frequently present as sudden confusion, brief staring, unexplained behavioral changes, or periods of unresponsiveness — events that are routinely attributed to the dementia itself and rarely flagged as possible seizure activity.
The dementia-seizure overlap is one of the most understudied intersections in aging medicine. New peer-reviewed evidence is published regularly — and most of it never reaches the people closest to these cases.
Seagull Pulse changes that. It doesn't replace clinical judgment. It makes sure the evidence exists in the room when you need it.
What you get
Every Monday, Seagull Pulse delivers a curated digest of new PubMed papers on seizures in dementia — screened for clinical relevance and organized by topic.
Diagnosis & Recognition
Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease
Why It Matters
More than half of seizures in early Alzheimer's disease in this study were nonconvulsive — no visible shaking, no dramatic presentation. Routine EEG missed many cases; extended or serial monitoring was needed to detect epileptiform activity. For care settings relying on clinical observation alone, this is a direct challenge to the assumption that no convulsions means no seizure activity.
Summary
Retrospective study of 54 patients with early Alzheimer's disease or mild cognitive impairment who also had epilepsy, followed at UCSF's Memory and Aging Center. 55% of seizures were nonconvulsive. Patients with AD-associated epilepsy experienced cognitive decline onset 5.5 years earlier than those without epilepsy. Extended or serial EEG monitoring outperformed routine EEG at detecting epileptiform activity. Levetiracetam and lamotrigine showed favorable seizure control and tolerability.
→ PubMed PMID 23835471Management
Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity: A Randomized Clinical Trial
Why It Matters
This is one of the few randomized controlled trials examining whether treating underlying seizure activity in Alzheimer's disease can improve cognitive outcomes. Levetiracetam didn't benefit the broader AD group — but patients who had epileptiform activity (often undetected without specialized EEG) showed meaningful improvements in spatial memory and executive function. The implication: treatment response depends on accurate detection first.
Summary
Phase 2a randomized double-blind crossover trial of 34 adults with Alzheimer's disease. Participants received levetiracetam 125mg twice daily or placebo across 4-week periods. Overall, levetiracetam did not improve the primary executive function outcome. Among the 38% of participants with confirmed epileptiform activity, levetiracetam improved performance on spatial memory and executive function tasks. No participants discontinued treatment due to adverse effects.
→ PubMed PMID 34570177Pre-screened for relevance
Every result is evaluated before it reaches you. Non-clinical and off-topic papers are removed. What remains is directly relevant to the dementia-seizure overlap.
Why It Matters — practical takeaways
Every paper includes a plain-language section on clinical relevance — not a restatement of the abstract, but a direct answer to: what does this mean for people working in this field?
Organized by topic
Papers sorted into six categories: Diagnosis, Epidemiology, Pathophysiology, Metabolic, Management, and General & Background.
Direct links to source
Every summary includes the PubMed link. Read the abstract, pull the full text — the paper is always one click away.
Delivered every Monday
Automated weekly cadence. No searching PubMed. No missing a paper because you didn't check. It comes to you.
How it works
Seagull Pulse runs on the same AI infrastructure Seagull Health uses to produce clinical intelligence reports for legal and investment professionals — adapted to run automatically every week.
PubMed is searched
A structured Boolean query runs against PubMed every Monday. Human studies only. Clinical publication types only. Results sorted by publication date.
Papers are screened
Each result is evaluated for clinical relevance. Animal models, molecular biology, and off-topic papers are removed. What remains is directly relevant to the dementia-seizure clinical field.
Summaries are written
Passing papers are categorized, summarized in plain language, and given a "Why It Matters" section — a practical clinical takeaway, not an abstract restatement.
Delivered to your inbox
The issue is assembled and sent directly to subscribers. No login required. No app. Just your email.
Pricing
One product. Two ways to pay. Cancel anytime.
Monthly
$29
per month
Includes
Weekly dementia-seizure digest
Pre-screened PubMed literature
Plain-language summaries
Why It Matters — practical takeaways
Direct links to source papers
Full issue archive
Subscribe monthlyAnnual
$249
per year
$20.75/month · billed annually
Everything in Monthly, plus
Weekly dementia-seizure digest
Pre-screened PubMed literature
Plain-language summaries
Why It Matters — practical takeaways
Direct links to source papers
Full issue archive
Annual year-end research synthesis
Quarterly DSS domain coverage notes
Subscribe annually
Secure checkout via Stripe. Cancel monthly plans anytime.
Annual plans are non-refundable after 14 days. Questions? info@seagullhealth.global
About
Seagull Health is a clinical intelligence company specializing in the dementia-seizure overlap. Our CRISP platform is used by nursing home negligence attorneys and senior housing investors to analyze the peer-reviewed evidence base on seizure risk in long-term care settings.
Seagull Pulse is a separate product — built to make the same evidence accessible without the clinical intelligence report format. Same source literature. Same relevance standards. Delivered weekly.
seagullhealth.global · Seizure Clarity in Dementia